Top 10 DigitalHealth/ HealthTech Capital Raises in the U.S. – November 16th-30th, 2024
Several interesting transactions closed in the DigitalHealth/ HealthTech sector over the past two weeks. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
Buyout/LBO
- Carebox, developer of an automated patient medical record platform designed to connect patients, families, and their physicians with treatment options only available in clinical trials, acquired by H.I.G. Growth Partners through an LBO.
- Twiage, developer of a prehospital communication and coordination technology designed to accelerate emergency care and enhance non-emergency services, acquired by TigerConnect, via its financial sponsor Vista Equity Partners, through an LBO.
Later Stage VC
- Citizen Health, developer of an online healthcare data platform designed to help patients collect, organize, and share their medical records digitally, raised $14.5 million of venture funding in a deal led by Transformation Capital.
- Click Therapeutics, developer of software as medical treatments prescription platform designed to deliver safe and effective digital treatments to patients in need, raised $11.27 million of venture funding.
- ai, developer of brain image analysis software designed to offer better clinical insight through quantitative imaging, raised $14 million through a combination of Series C and Series C1 venture funding in a deal led by VILAS Ventures.
- Deep 6 AI, developer of clinical data software designed to expedite the process of finding patients for clinical trials, raised $2.5 million of venture funding.
Early Stage VC
- Roon, Developer of a health platform designed for challenging health conditions, raised $15 million of Series A venture funding in a deal led by FirstMark Capital and Forerunner Ventures.
- Waltz Health, Developer of consumer tools designed to guide decisions on prescription care designed with payers and consumers in mind, raised $17.5 million of venture funding.
Seed Round
- Modulo Bio, developer of digital biology mechanisms designed to accelerate the discovery of therapeutic targets harnessing autoimmunity, raised $5.85 million through a combination of Seed-1, Seed-2, and Seed-3 funding from Calm Ventures and other investors.
- NXgenPort, developer of a digital health technology designed to maximize remote care for cancer patients, raised seed funding from CANCER FUND.
#castleplacement #capitalraising #privateequity #venturecapital #investment #digitalhealth #health #healthtechnology
Tamara Williams
Managing Director
15+ years of experience in investment banking and financial structuring including private equity, acquisitions, fund management and raising debt capital within various sectors including real estate, oil and gas, hospitality, serviced offices, IT and trading. Advised on investment opportunities, capital structure, holding and tax structure. Skilled at conducting due diligence, company valuation and providing real estate development project oversight. International network extending from the US, UK, France, Russia, and the Middle East to Asia. Previously held several senior management positions in the financial industry. Master of Business Administration with Distinction from the University of Northampton UK. Higher National Diploma with Distinction from ABE UK. FINRA Series 7, 79, and 66 licenses.
- twilliams@castleplacement.com
- (385) 600-1871
 Tamara WilliamsManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
